David Mott became chief executive officer of MedImmune in October 2000. He joined the company in April 1992 as vice president, with responsibility for business development, strategic planning and investor relations. Prior to joining MedImmune, Mr. Mott was a vice president in the Health Care Investment Banking Group at Smith Barney, Harris Upham & Co., Inc. Mr. Mott is chairman of the board of directors of Conceptis Technologies and also serves on the boards of directors of the Biotechnology Industry Organization (BIO) and the Technology Council of Maryland, the board of trustees of St. James School, and the board of governors of Beauvoir, the National Cathedral Elementary School. He holds a bachelor's degree in economics and government from Dartmouth College.